UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 47

Sortiert nach

A Phase 1b Safety Study of SER-287, a Spore-Based Microbiome Therapeutic, for Active Mild to Moderate Ulcerative Colitis

Gastroenterology (New York, N.Y. 1943), 2021-01, Vol.160 (1), p.115-127.e30

2021

Volltextzugriff (PDF)

SER-109, an Investigational Microbiome Drug to Reduce Recurrence After Clostridioides difficile Infection: Lessons Learned From a Phase 2 Trial

Clinical infectious diseases, 2021-06, Vol.72 (12), p.2132-2140

2021

Volltextzugriff (PDF)

SER-109, an Oral Microbiome Therapy for Recurrent Clostridioides difficile Infection

The New England journal of medicine, 2022-01, Vol.386 (3), p.220-229

2022

Volltextzugriff (PDF)

Drugging the microbiome and bacterial live biotherapeutic consortium production

Current opinion in biotechnology, 2022-12, Vol.78, p.102801-102801, Article 102801

2022

Volltextzugriff (PDF)

Manufacturing Processes of a Purified Microbiome Therapeutic Reduce Risk of Transmission of Potential Bacterial Pathogens in Donor Stool

The Journal of infectious diseases, 2023-11, Vol.228 (10), p.1452-1455

2023

Volltextzugriff (PDF)

Manufacturing Process of SER-109, a Purified Investigational Microbiome Therapeutic, Reduces Risk of Coronavirus Transmission From Donor Stool

Open forum infectious diseases, 2022-09, Vol.9 (9), p.ofac448-ofac448

2022

Volltextzugriff (PDF)

A Novel Microbiome Therapeutic Increases Gut Microbial Diversity and Prevents Recurrent Clostridium difficile Infection

The Journal of infectious diseases, 2016-07, Vol.214 (2), p.173-181

2016

Volltextzugriff (PDF)

Quantitative Studies of Cell-Bubble Interactions and Cell Damage at Different Pluronic F-68 and Cell Concentrations

Biotechnology progress, 2004-07, Vol.20 (4), p.1183-1191

2004

Volltextzugriff (PDF)

Characterization of changes in PER.C6™ cellular metabolism during growth and propagation of a replication-deficient adenovirus vector

Biotechnology and bioengineering, 2005-06, Vol.90 (5), p.645-655

2005

Volltextzugriff (PDF)

Vaccine Technology III: An ECI Conference held in Puerto Vallarta, Mexico from June 6–11, 2010

Vaccine, 2011-09, Vol.29 (41), p.7115-7116

2011

Volltextzugriff (PDF)

Fluid mechanics, cell distribution, and environment in CellCube bioreactors

Biotechnology progress, 2003, Vol.19 (1), p.2-8

2003

Volltextzugriff (PDF)

Phosphate feeding improves high-cell-concentration NS0 myeloma culture performance for monoclonal antibody production

Biotechnology and bioengineering, 2000-09, Vol.69 (5), p.566-576

2000

Volltextzugriff (PDF)

Production and Formulation of Adenovirus Vectors

Advances in biochemical engineering, biotechnology, 2005-01, Vol.99, p.193-260

2005

Volltextzugriff (PDF)

Serum-free suspension cultivation of PER.C6® cells and recombinant adenovirus production under different pH conditions

Biotechnology and bioengineering, 2002-12, Vol.80 (5), p.569-579

2002

Volltextzugriff (PDF)

Large-scale mammalian cell culture

Current opinion in biotechnology, 1997-04, Vol.8 (2), p.148-153

1997

Volltextzugriff (PDF)

Large-scale propagation of a replication-defective adenovirus vector in stirred-tank bioreactor PER.C6™ cell culture under sparging conditions

Biotechnology and bioengineering, 2003-07, Vol.83 (1), p.45-52

2003

Volltextzugriff (PDF)

293 cell cycle synchronisation adenovirus vector production

Biotechnology progress, 2009-01, Vol.25 (1), p.235-243

2009

Volltextzugriff (PDF)

Monoclonal Antibody Process Development Using Medium Concentrates

Biotechnology progress, 1994-01, Vol.10 (1), p.87-96

1994

Volltextzugriff (PDF)

Hydrodynamic effects on BHK cells grown as suspended natural aggregates

Biotechnology and bioengineering, 1995-05, Vol.46 (4), p.351-360

1995

Volltextzugriff (PDF)

Scaleable Production of Adenoviral Vectors by Transfection of Adherent PER.C6 Cells

Biotechnology progress, 2007-09, Vol.23 (5), p.1210-1217

2007

Volltextzugriff (PDF)

Comparative analysis of the effects of packaging signal, transgene orientation, promoters, polyadenylation signals, and E3 region on growth properties of first-generation adenoviruses

Human gene therapy, 2003-07, Vol.14 (10), p.1017-1034

2003

Volltextzugriff (PDF)

Formation and disruption of animal cell aggregates in stirred vessels: Mechanisms and kinetic studies

Chemical engineering science, 1995-09, Vol.50 (17), p.2747-2764

1995

Volltextzugriff (PDF)

WITHDRAWN:Manufacturing Process of Investigational Microbiome Therapeutic, SER-109, Reduces Risk of Bacterial Pathogen Transmission

Gastro hep advances, 2023-01

2023

Volltextzugriff (PDF)

Biochemical engineering

Current opinion in biotechnology, 2004-10, Vol.15 (5), p.441-443

2004

Volltextzugriff (PDF)

Production of core and virus-like particles with baculovirus infected insect cells

Advances in biochemical engineering, biotechnology, 2002, Vol.74, p.183

2002

Volltextzugriff (PDF)

1 – 25 von 47

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(43)
Mit Volltextzugriff
(46)

Publikationsform

Sprache

Englisch
(47)
Japanisch
(8)

Erscheinungsjahr

n.n

Thema

Science & Technology
(29)
Life Sciences & Biomedicine
(26)
Biological And Medical Sciences
(17)
Biotechnology
(17)
Biotechnology & Applied Microbiology
(17)
Fundamental And Applied Biological Sciences. Psychology
(17)
Humans
(14)
Cell Line
(10)
Eukaryotic Cell Cultures
(10)
Methods. Procedures. Technologies
(10)
Animal Cells
(9)
Animals
(7)
Cell Culture Techniques - Methods
(6)
Adenoviridae - Growth & Development
(5)
Adenovirus
(5)
Food Science & Technology
(5)
Immunology
(5)
Infectious Diseases
(5)
Microbiology
(5)
Microbiota
(5)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A Phase 1b Safety Study of SER-287, a Spore-Based Microbiome Therapeutic, for Active Mild to Moderate Ulcerative Colitis

SER-109, an Investigational Microbiome Drug to Reduce Recurrence After Clostridioides difficile Infection: Lessons Learned From a Phase 2 Trial

SER-109, an Oral Microbiome Therapy for Recurrent Clostridioides difficile Infection

Drugging the microbiome and bacterial live biotherapeutic consortium production

Manufacturing Processes of a Purified Microbiome Therapeutic Reduce Risk of Transmission of Potential Bacterial Pathogens in Donor Stool

Manufacturing Process of SER-109, a Purified Investigational Microbiome Therapeutic, Reduces Risk of Coronavirus Transmission From Donor Stool

A Novel Microbiome Therapeutic Increases Gut Microbial Diversity and Prevents Recurrent Clostridium difficile Infection

Quantitative Studies of Cell-Bubble Interactions and Cell Damage at Different Pluronic F-68 and Cell Concentrations

Characterization of changes in PER.C6™ cellular metabolism during growth and propagation of a replication-deficient adenovirus vector

Vaccine Technology III: An ECI Conference held in Puerto Vallarta, Mexico from June 6–11, 2010

Fluid mechanics, cell distribution, and environment in CellCube bioreactors

Phosphate feeding improves high-cell-concentration NS0 myeloma culture performance for monoclonal antibody production

Production and Formulation of Adenovirus Vectors

Serum-free suspension cultivation of PER.C6® cells and recombinant adenovirus production under different pH conditions

Large-scale mammalian cell culture

Large-scale propagation of a replication-defective adenovirus vector in stirred-tank bioreactor PER.C6™ cell culture under sparging conditions

293 cell cycle synchronisation adenovirus vector production

Monoclonal Antibody Process Development Using Medium Concentrates

Hydrodynamic effects on BHK cells grown as suspended natural aggregates

Scaleable Production of Adenoviral Vectors by Transfection of Adherent PER.C6 Cells

Comparative analysis of the effects of packaging signal, transgene orientation, promoters, polyadenylation signals, and E3 region on growth properties of first-generation adenoviruses

Formation and disruption of animal cell aggregates in stirred vessels: Mechanisms and kinetic studies

WITHDRAWN:Manufacturing Process of Investigational Microbiome Therapeutic, SER-109, Reduces Risk of Bacterial Pathogen Transmission

Biochemical engineering

Production of core and virus-like particles with baculovirus infected insect cells

Suchergebnisse filtern